AKBA

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

3-O-Acetyl-11-keto-beta-boswellic Acid 可抑制 5-脂氧合酶产物的形成，IC(5) 为 1.5 m muM。

AKBA is an antiangiogenic and neuroprotective agent, reducing the impact of proliferative retinopathies, protecting neurons against ischemic injury involving the Nrf2/HO-1 pathway. It selectively inhibits 5-lipoxygenase (IC50 = 1.5 μM) in an enzyme-directed, nonredox, and noncompetitive manner.2 3-acetyl-11-keto-β-Boswellic acid and other members of the boswellic acid family have been studied for potential use in the control of inflammatory diseases, including arthritis and cancer.

——

——

AKBA | 3-O-acetyl-11-keto-β-Boswellic acid

Others

Other Targets

Others

Cancer

——

67416-61-9

512.73

C32H48O5

>98% (HPLC)

DMSO : ≥ 5.2 mg/mL; 10.14 mM

CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(C5(C)C(=O)O)OC(=O)C)C)C)C2C1C)C)C

(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bS)-3-acetyloxy-4,6a,6b,8a,11,12,14b-heptamethyl-14-oxo-1,2,3,4a,5,6,7,8,9,10,11,12,12a,14a-tetradecahydropicene-4-carboxylic acid

(-20℃)

With Ice Pack

≥ 2 years